Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05098366 · ClinicalTrials.gov registry record · Early Phase 1
Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound
A Early Phase 1 study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 42
- Enrollment target
NCT05098366: Completed Early Phase 1 study, sponsored by Connecticut Children's Medical Center.
NCT05098366 is a Early Phase 1 study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 42 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05098366, a Early Phase 1 study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.
Primary Outcome
Initiation of the intervention is defined as administration of furosemide vs. normal saline flush.
Interventions
- DRUG Normal saline
- DRUG Furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-05-29 |
| Est. Completion | 2023-12-31 |
| Phase | Early Phase 1 |
What the finished NCT05098366 record still lists
NCT05098366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT05098366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05098366 about?
NCT05098366 is a clinical study titled "Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound". The purpose of this study is to investigate whether or not furosemide causes the bladder to fill faster than IV fluids alone so that a pelvic ultrasound exam can be performed.
What is the current status of trial NCT05098366?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 42 participants. The study started on 2021-05-29. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT05098366?
The interventions under investigation include: Normal saline (DRUG), Furosemide (DRUG).
Who is sponsoring clinical trial NCT05098366?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05098366's enrollment target sits among peer trials
42 605th of 2000 higher than 1,379 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI